Investor Presentation for the May, 2025
TRANSPEK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transpek Industry reported FY25 revenue of Rs. 678.6 Cr, up 12.2% YoY, with EBITDA rising 14.8% to Rs. 123.4 Cr (margin 18.2%, up from 17.8%) and PAT jumping 26.4% to Rs. 48.7 Cr. Q4 FY25 was particularly strong, with revenue of Rs. 173 Cr (+13.1% YoY), EBITDA margin expanding sharply to 23.1% from 15.4%, and PAT nearly tripling to Rs. 19.3 Cr. The company is expanding geographically into South America, Eurasia, and Japan, and has introduced two new acid chlorides with more in development. Management guided an average EBITDA margin range of 16-20%, noting it can vary based on product mix. The Board recommended a 200% dividend (Rs. 20 per share) for FY25, and the company received the EcoVadis Gold Medal for sustainability.
Strong FY25 results with margin expansion and a healthy dividend payout are positive for shareholders. Geographic and product diversification reduce concentration risk, while strong cash generation (operating cash flow of Rs. 135 Cr) supports growth investments. The stock could see positive sentiment given the robust Q4 performance and forward-looking growth strategy.